Source: Owler

Galectin Therapeutics, Inc.: Galectin's employee count had no change from Feb 2024 to Feb 2025

Galectin’s employee count had no change from 14 to Feb 2024.

Galectin Therapeutics, Inc.'s Competitors | Galectin Therapeutics, Inc.'s News | Galectin Therapeutics, Inc.'s Financials

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

1-25

President & CEO

Joel Lewis

CEO Approval Rating

85/100

Galectin is a Georgia-based biotechnology company that develops and commercializes galectin protein drug therapeutics for the treatment of cancer and liver disease.